Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at
death, and there is a lack of routine postmortem examinations. These factors are thought to …

Background The total annual number of VTE events and related deaths in the US is
unknown, largely because the complete spectrum of disease (including asymptomatic …

Background—Studies on long-term mortality after venous thromboembolism (VTE) are
sparse. Methods and Results—Using Danish medical databases, we conducted a 30-year …

Abstract Changes in the incidence of venous thromboembolism (VTE) during the last two
decades have not been extensively studied. Therefore, we studied time trends in the …

INTRODUCTION: Information on the epidemiology and long-term clinical outcome of venous
thromboembolism (VTE) is mainly based on data from clinical trials and thus may be not …

Healthcare reform is upon the United States (US) healthcare system. Prioritisation of
preventative efforts will guide necessary transitions within the US healthcare system. While …

The burden of venous thromboembolism (VTE) remains high in the United States (US). This
study assesses the rate of VTE prophylaxis in a large real-world population of medically ill …

Venous thromboembolism is a major health problem, with an incidence that exceeds 1 per
1000. Over 200,000 new cases occur in the United States annually. Of these, 30% of …

Background: Estimates of the incidence of venous thrombosis (VT) vary, and data on
mortality are limited. Objectives: We estimated the incidence and mortality of a first VT event …

While there have been advances in prophylaxis and management of venous
thromboembolism (VTE), there are a dearth of data from the perspective of a community …